Table of Contents

Article

• Article

  The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines

  Chafiq Hamdouchi, Heather Keyser, Elizabeth Collins, Carlos Jaramillo, Jose Eugenio De Diego, Charles D. Spencer, Jack Alan Dempsey, Bryan D. Anderson, Tillie Leggett, Nancy B. Stamm, Richard M. Schultz, Scott A. Watkins, Kim Cocke, Stephanie Lemke, Teresa F. Burke, Richard P. Beckmann, Jeffrey T. Dixon, Thomas M. Gurganus, Nancy B. Rankl, Keith A. Houck, Faming Zhang, Michal Vieth, Juan Espinosa, David E. Timm, Robert M. Campbell, Bharvin K. R. Patel and Harold B. Brooks

  Mol Cancer Ther January 1 2004 3 (1) 1-9;

  
  
• Article

  Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines

  Beverly E. Barton, James G. Karras, Thomas F. Murphy, Arnold Barton and Hosea F-S. Huang

  Mol Cancer Ther January 1 2004 3 (1) 11-20;

  
  
• Article

  Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes

  Maria Nunes, Celine Shi and Lee M. Greenberger

  Mol Cancer Ther January 1 2004 3 (1) 21-27;

  
  
• Article

  CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

  Tomohiko Mori, Ryuichiro Doi, Masayuki Koizumi, Eiji Toyoda, Daisuke Ito, Kazuhiro Kami, Toshihiko Masui, Koji Fujimoto, Hirokazu Tamamura, Kenichi Hiramatsu, Nobutaka Fujii and Masayuki Imamura

  Mol Cancer Ther January 1 2004 3 (1) 29-37;

  
  
• Article

  Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid

  Takashi Ikeda, Yukiko Nakata, Fumihiko Kimura, Ken Sato, Kenneth Anderson, Kazuo Motoyoshi, Michael Sporn and Donald Kufe

  Mol Cancer Ther January 1 2004 3 (1) 39-45;

  
  
• Article

  Biological characterization of MLN944: A potent DNA binding agent

  Darshan S. Sappal, A. Kathleen McClendon, James A. Fleming, Vala Thoroddsen, Kelly Connolly, Corinne Reimer, Ronald K. Blackman, Christine E. Bulawa, Neil Osheroff, Peter Charlton and Laura A. Rudolph-Owen

  Mol Cancer Ther January 1 2004 3 (1) 47-58;

  
  
• Article

  The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts

  Steffan T. Nawrocki, Bridget Sweeney-Gotsch, Ryan Takamori and David J. McConkey

  Mol Cancer Ther January 1 2004 3 (1) 59-70;

  
  
• Article

  Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis

  Ali R. Jazirehi and Benjamin Bonavida

  Mol Cancer Ther January 1 2004 3 (1) 71-84;

  
  
• Article

  Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptides

  Takashi Kurizaki, Michio Abe, Sam D. Sanderson, Charles A. Enke and Janina Baranowska-Kortylewicz

  Mol Cancer Ther January 1 2004 3 (1) 85-91;

  
  
• Article

  Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo

  Shoichiro Ohtani, Shunsuke Kagawa, Yasuhisa Tango, Tatsuo Umeoka, Naoyuki Tokunaga, Yousuke Tsunemitsu, Jack A. Roth, Yoichi Taya, Noriaki Tanaka and Toshiyoshi Fujiwara

  Mol Cancer Ther January 1 2004 3 (1) 93-100;